Republic of the Philippines

DEPARTMENT OF HEALTH
Office of the Secretary
BAGONG PILIPINAS

July 10, 2025

DEPARTMENT MEMORANDUM
No.2025-_D318

FOR: ALL UNDERSECRETARIES. ASSISTANT SECRETARIE

DIRECTORS OF BUREAUS. SERVICES. AND CENTERS
FOR HEALTH DEVELOPMENT (CHD). MINISTER OF
- V T

MUSLIM MINDANAO (MOH-BARMM). ATTACHED

ENCIES. AND OTHERS CONCERNED

SUBJECT: Revised Guidelines on the Implementation of School-based

Immunization (SBI)

I. BACKGROUND

The School-based Immunization (SBI) program, implemented by the Department of

Health (DOH) in collaboration with the Department of Education (DepEd), aims to protect
school-aged children against vaccine-preventable diseases (VPDs) such as measles, rubella,
tetanus, diphtheria, and human papillomavirus (HPV). Since its inception in 2013, the SBI
has been conducted annually every August in public schools nationwide, until it was
suspended due to the COVID-19 pandemic.

In 2024, the program was resumed as part of broader initiatives to improve student
health. With the full resumption of face-to-face classes, learners are at increased risk of
contracting VPDs. Therefore, sustaining the delivery of immunization services, including
school-based vaccination, is
critical to preventing potential public health crises and outbreaks.

This issuance provides technical guidelines to enhance the implementation of

school-based immunization services.

II. GENERAL GUIDELINES

A. All SBI services, including Measles-Rubella (MR), Tetanus-diphtheria (Td), and

Human Papillomavirus (HPV) vaccination, shall resume its implementation in
schools. It is recommended to be rolled out in public schools two (2) months from
the start of classes or as agreed upon by DOH and DepEd.
B. Grade 1 and Grade 7 school children shall be vaccinated with MR and Td vaccines
while Grade 4 female school children shall be vaccinated with HPV vaccine.
These vaccinations shall follow the appropriate dosages, scheduling and intervals.
C. A template for informed consent (4nnex A), including information, education, and
communication (IEC) materials shall be disseminated to parents or guardians prior
to the SBI roll-out.

Building 1, San Lazaro Compound, Rizal Avenue, Sta. Cruz, 1003 Manila ® Trunk Line 651-7800 local 1113, 1108, 1135
Direct Line: 711-9502; 711-9503 Fax: 743-1829 URL: http://www.doh.gov.ph; e-mail: dohosec(@ doh. gov ph
 D. Proper microplanning, coordination, and demand generation activities shall be
undertaken by all local government units (LGUs) and local health workers
concerned, in collaboration with other stakeholders such as the Department of

~~
Education (DepEd) and other national government agencies (NGAs), to ensure the
efficiency in managing health resources and highlight the distinction of the
MR-Td and HPV school-based immunization from other ongoing vaccination
services.

III. SPECIFIC GUIDELINES

A. Preparatory Activities

1. Coordination and Engagement with School Administration

a. Regional immunization coordinators shall coordinate with their respective
DepEd offices to collect aggregated enrolment data, disaggregated by
school name, grade level, and gender. They shall transmit the consolidated
data using the template through this link:
https://tinyurl.com/VaccTrackRegionSBI to the Disease Prevention and
Control Bureau — National Immunization Program (DPCB-NIP) at least
one week prior to the scheduled vaccination activities.
The LGUs shall coordinate with schools to secure the masterlist of
enrollees for vaccination. Schools within the LGU catchment area shall
endorse the list of Grade 1. Grade 7, and female Grade 4 children enrolled
for the current school year to the local health center.
Local health centers shall coordinate with school principals, teachers and
school nurses on the conduct of SBI activities and SBI guidelines
orientation.
Teachers-in-charge/school nurses shall issue notification letters and
consent forms (Annex 4). The template for notification letter and informed
consent may be accessed through: https:/bit.ly/SBIConsentForm.
Local health center staff shall record the endorsed list of eligible school
children in the Recording Forms 1, 2, and 3 (Annexes B, C, D). The
recording forms may be accessed via: https:/tinyurl.com/SBIReporting.

2. Microplanning
a. All LGUs, assisted by the DOH Development Management Officers
(DMO) with guidance of NIP Managers, shall develop a detailed
microplan of the SBI activities. Micro-plans shall include the following:
i. Calculation and identification of the number of children to be
vaccinated per immunization session and the vaccination teams
needed to prepare immunization schedules for the vaccination team

ii.
to
including the schools be visited;
Calculation of the vaccines and other logistics needed including the
cold chain equipment;
iii. Immunization session plans;
iv. Plan for high-risk and hard-to-reach population;
v. Crafting of supervisory and monitoring schedule;
vi. Follow-up schedule and mop-up plan;
vii. Human resource mapping and contingency plan;
 viii. Demand generation plan;
ix. Disease surveillance and reporting;
X. Adverse Events Following Immunization (AEFI) management plan;

~~
and
xi. Waste management plan
All SBI operational resource requirements shall be consolidated at the
city/municipality, provincial and regional levels and shall be reviewed by
the next higher administrative level.
A standard microplan template which can be accessed through
https:/tinyurl.com/SBIMicroplanTemplate shall be used by all LGUs.
3. Conduct of SBI Readiness Assessment
a. CHDs, LGUs, and schools shall accomplish the Readiness Assessment
Tool (RAT) using the links provided in Annex E, which are also accessible
via https:/tinyurl.com/SBIReporting. Implementers are advised to conduct
the RAT at least three times—at 6 weeks, 4 weeks, and 2 weeks prior
scheduled implementation date—or more frequently as needed.
tothe

Results from the RAT shall be used to evaluate their readiness and capacity
to implement SBI and identify areas requiring technical assistance.

4. Demand Generation
a. School health personnel, with support from rural health unit staff, shall
engage parents and caregivers in discussions about immunization activities
during Parent-Teacher Association (PTA) conferences and similar
gatherings, using social listening and feedback to guide communication.
Dissemination of scheduled vaccination sessions among students may be
done through platforms such as flag ceremonies, lectures in health classes,
student council meetings, and/or activities to raise awareness and
willingness among students.
LGUs and schools shall mobilize stakeholders to support demand
generation activities. This can include the provision of giveaways for
successfully vaccinated students, as well as incentives for health workers.
Other interactive community engagement activities such as contests and
kick-oft/launching activities are also encouraged.

5. Setting up of Vaccination Posts

a. Local health centers shall coordinate with the school administrators for the
use of school facilities as temporary vaccination posts. The school and the
LGU shall jointly determine the optimal frequency of vaccination sessions
to minimize class disruption while preventing vaccine wastage through
efficient session planning.
LGUs shall plan the ideal client flow for immunization sessions with
school administrators, teachers-in-charge, and school nurses. The layout of
temporary vaccination posts must ensure adequate ventilation and
sufficient space to comply with existing immunization protocols.

6. Establishment of Vaccination Teams

a. A vaccination team shall be composed of at least three (3) trained
 personnel composed of one (1) vaccinator, one (1) recorder and one (1)
health counselor.
b. Vaccination teams shall be organized based on the target number of

~~
schoolchildren to be vaccinated per immunization session and shall apply
the following strategies:
i. The LGUs shall identity available human resources for deployment
based on the calculated number of vaccination teams needed and
identify the gap for possible HR augmentation from stakeholders/

ii.
partnersin to
order reach the target.
Schedule vaccination sessions and deployment of vaccination teams
giving priority to schools with a high number of eligible children
that are close in their respective area of jurisdiction, and/ or areas
with cases of measles-rubella.
iii. LGUs shall collaborate with volunteer medical groups, medical
societies, and civil society organizations to augment vaccination
implementation, in coordination with DepEd.
7. Orientation and Training
Pre-deployment orientation and capacity—building activities on SBI guidelines
shall be conducted for all primary healthcare workers, vaccination teams,
school personnel, and other stakeholders participating in this activity.
Orientation shall be provided by the Provincial and City Health Offices with
the assistance of the National Immunization Program coordinators of the CHD.

B. School-Based Immunization (SBI) Roll-Out

1. Conduct of Immunization Sessions
a. Vaccination teams may request support from Barangay Local Government
Units (BLGUs) for the mobilization and transportation of vaccination teams to
the different school vaccination locations as scheduled.
Only students from the school itself can take part in the immunization sessions
held on school premises.
Consenting parents/guardians of Grade 1, Grade 7. and female Grade 4 school
children shall complete and submit the consent forms on/or before the
scheduled SBI immunization session.
The vaccinator shall conduct a quick health assessment prior to administration
of MR, Td, and HPV vaccines using the recommended form (Annex F) to
ensure that the child is well enough to be vaccinated.
Antigens administered during the SBI shall be recorded as a supplemental dose
in the SBI vaccination card (Annex G) or if available, in their routine
immunization card, Mother and Child booklet.
Parents and guardians shall be reminded to keep the child’s immunization card
of
as it will be used as a means verification of the child's vaccination status.
2. MR-Td and HPV Immunization Target Population, Schedules, and Operations

a. Local health center staff shall be in charge of checking the school children’s
vaccination status and consolidating informed consents for SBI.
b. Target school children shall receive the following recommended vaccines:
 Table 1. Recommended vaccines for school-based immunization.
Vaccine acoAtion
History
Vaccine Schedule Dosage
Grade 1 Students
0.5mL
: subcutaneous
MR Irrespective One (1) dose
(SQ), Right upper
arm
0.5mL
Td Irrespective One (1) dose intramuscular

i
(IM), Left deltoid
Grade 7 Students
0.5mL SQ, Right
Irrespective One (1) dose
MR upper ati
0.5mL, IM, Left
Td One (1) dose
;

Irrespective
deltoid
Grade 4 Female Students
0.5ml IM, left
Zero (0) dose HPV1
deltoid

HPV
One
:
1)
previousEa .
implementation
) HPV2 to
year community-based
oo
be
administered at the |0.5ml, IM left
|deltoid
)

setting

Twa (2) doses Vaccination not Notie

required

c. Timing and spacing of MR, Td, or HPV vaccines with other vaccines shall
follow standard immunization rules:
i. Inactivated vaccines such as Td and HPV can be given with other
vaccines at any interval.
ii. Live, attenuated vaccines such as MR can be administered on the
following conditions:
1. If to be given with another live attenuated vaccine, it should be
administered simultaneously or with a 28-day interval if not given
simultaneously/on the same day.
2. If to
be given with an inactivated vaccine (e.g. Td), may administer
any time with no interval.
iii. Co-administration of vaccines in one session must be done using separate
syringes and different injection sites.
All vaccinated students shall be recorded in Recording Forms 1, 2 and 3.
e. In compliance with Healthy Learning Institutions standards, private schools
who wish to participate in school-based immunization shall directly coordinate
with their respective local health centers. Eligible private school children shall
also be recorded in the Recording Forms.
 f. End-of-cycle mop-up activities. Mop-up activities shall be provided to those
students who have not completed their recommended immunization schedule.
The local health center shall inform the teacher-in-charge or school nurse of
available activities. These include scheduling of additional vaccination days
in school or referring students for immunization sessions to the local health
center.
1. A mop-up activity may be scheduled for all eligible students who were
initially deferred for MR, Td, or HPV immunization. Parents or
caregivers of eligible students who missed the initial roll-out and
catch-up activity and express willingness to get vaccinated shall be
referred to the nearest implementing local health center. The student shall
be accompanied by their parents and/or caregivers and shall be instructed
to bring their duly accomplished consent form, provided that there are
still available vaccines.

3. Supply Chain and Logistics Management

a. Vaccine Supply and Inventory Management

i. All MR, Td, and HPV vaccines and ancillaries shall be provided by the
DOH Central Office (CO).
ii. The quantity of the vaccines and supplies to be allocated and provided
to the CHDs shall be based on the consolidated number of enrolled
students per region. Requested quantities will be reviewed and adjusted
based on inventory reports and vaccine requirements at the level of the
LGU. Quantification for vaccines and ancillaries shall be done using
the microplan template (https:/tinyurl.com/SBIMicroplanTemplate).
iii. All provinces/cities shall adhere to their regular monthly reporting and
updating of vaccine inventories (MR, Td and HPV) received and issued
through the electronic logistics management information system
(eLMIS).
b. Vaccine Handling and Storage
1 MR, Td, and HPV vaccines shall be maintained at +2°C to +8°C at all
times during distribution, storage, and immunization sessions.
1. MR vaccines should not be exposed to over 8°C beyond one (1)
hour;
2. Td vaccines must never be frozen;
3. HPV vaccines should be protected from light.
Vaccine vials with vaccine vial monitors (VVMs) at discard point shall
properly be disposed of.
iii. Vaccine vials and diluents must be placed in standard vaccine carriers.
Standard vaccine carriers should have four (4) conditioned ice packs.
Newer vaccine carriers have seven (7) conditioned ice packs.
iv. Pre-filling ofsyringes ofvaccines is NOT allowed.
Any remaining reconstituted MR vaccine doses must be discarded after
six (6) hours or at the end of the immunization session, whichever
comes first. Unused reconstituted vaccine MUST NEVER be returned
to the refrigerator.
 vi. Open vials of Td vaccine follow the multi-dose vial policy (MDVP). As
such, these may be used in subsequent sessions (up to 28 days from
opening) provided the following conditions are met:

~~
date has not passed
= Expiry
Vaccines are stored under appropriate cold chain conditions
Vaccine vial septum has not been submerged in water
Gi Aseptic technique has been used to withdraw all doses
Vaccine Vial Monitor (VVM) is intact and has not reached the
discard point
6. Date is indicated when the vial was opened.
vii. Excess, unopened vaccine vials brought during immunization sessions
shall be marked with a check (V') before returning to the refrigerator for
storage. The check mark shall indicate that the vaccine vial was out of
the refrigerator and shall be prioritized for use in the next immunization
sessions.

C. Immunization Safety and Adverse Events Following Immunization (AEFI)

1. Special precautions must be instituted to ensure that blood-borne diseases will

not be transmitted during MR, Td, and HPV immunization. This shall include:
a. Use ofthe auto-disabled syringe (ADS) in all immunization sessions
b. Proper disposal of used syringes and needles into the safety collector box
and the safety collector boxes with used immunization wastes through the
recommended appropriate final disposal for hazardous wastes
oC Refrain from pre-filling of syringes, re-capping of needles, and use of
aspirating needles, as prohibited
Fear of injections resulting in fainting has been commonly observed in
adolescents during vaccination. Fainting is an immunization anxiety-related
reaction. To reduce its occurrence, it is recommended for vaccination sites to be
situated in areas not readily visible to the students. Further, the vaccinees shall
be:
a. Advised to eat before vaccination and be provided with comfortable room
temperature during the waiting period
Seated or lying down while being vaccinated
c. Carefully observed for approximately 15 minutes after administration ofthe
vaccine and provided with comfortable room temperature during the
observation period
The decision to proceed with or defer vaccination shall be based on the
professional judgment of the attending health personnel. Mild upper respiratory
infections are not considered contraindications to vaccination in general.
Adverse events following MR-Td and HPV vaccination are generally
non-serious and of short duration. However:
a. MR vaccine should NOT be given to a child or adolescent who:
i. Has a history of a severe allergic reaction (e.g., anaphylaxis) after a
previous dose ofthe vaccine or vaccine component (e.g. neomycin)
ii. Has a known severe immunodeficiency (e.g., from hematologic and
solid tumors, receipt of chemotherapy, congenital immunodeficiency,
or long-term immunosuppressive therapy or patients with human
immunodeficiency virus (HIV) infection who are severely
immunocompromised)
 ili. Pregnant females
b. Td vaccine should NOT be given to anyone who had a severe allergic
reaction (eg, anaphylaxis) after a previous dose.

~~
c. HPV vaccine should NOT be
given to adolescents who:
i Had a severe allergic reaction after a previous vaccine dose, or to a
component ofthe vaccine.
ii. Has a history of immediate hypersensitivity to yeast.
iii. Pregnant females. Although the vaccine has not been causally
associated with adverse pregnancy outcomes or adverse events to the
developing fetus, data on vaccination in pregnancy are limited.
5. Vaccine adverse reactions from any of the vaccines can be found in Annex J.
Reporting of AEFI shall follow the existing DOH Guidelines in Surveillance
and Response to Adverse Events Following Immunization using the form in
Department Circular No. 2023-0206 entitled Advisory on the Implementation
and Use of the Revised AEFI Case Investigation Form (CIF) Version 2023.
6. All vaccination teams and sites shall have at least one (1) complete AEFI kit
with first-line treatment drugs. These kits shall be replenished prior to each
vaccination run.
7. All vaccination team members shall be trained to detect, monitor, and provide
first aid for AEFI (e.g. anaphylaxis) and other health emergencies following
immunization. Prompt referral to the nearest health facility must be made in
such events.
8. Severe AEFI cases shall be immediately given first-line treatment (Annex I) and
promptly brought to the nearest tertiary health facility.
9. The DOH-retained and other government hospitals shall assess and manage
serious AEFI accordingly without any fee. In areas where there are no existing
or accessible government hospitals/health facilities, serious AEFI cases shall be
managed in private institutions and assistance shall be provided by the LGU
with support from the DOH in accordance with Administrative Order
2023-0007 entitled Revised Omnibus Guidelines on the Surveillance and
Management of Adverse Events Following Immunization (AEFI).
D. Data Management and Monitoring
1. Recording and Reporting
a. The vaccination teams shall utilize the SBI Recording Forms (Annex B-D)
as masterlists of Grade 1, Grade 7, and female Grade 4 school children.
b. The total number of children vaccinated per immunization session shall be
consolidated using the Summary Reporting Form (Annex H) and shall be
reported into VaccTrack (DM 2024-0375 entitled “Instructions for the
Implementation and Use of the Vacctrack System in Collecting Aggregate
Immunization Data.”)
Ii Eligible children who were initially deferred for MR, Td, or HPV
immunization in school and were later scheduled for vaccination at
the health center shall be reported to VaccTrack under
community-based immunization.
ii. Students from private schools shall also be included in the SBI
accomplishment reports, provided that the names ofthe participating
private schools are uploaded to VaccTrack.
 c. The procedure for submission ofreports should adhere to the guidelines
provided in Annex J.

Monitoring
The Disease Prevention and Control Bureau (DPCB), together with the HPB,
EB. KMITS, SCMS, and other DOH bureaus and offices, shall convene
meetings with the CHDs and MOH-BARMM every two weeks, or as necessary,
until the end of the SBI roll-out period. These meetings shall provide regular
updates, review plans, and recalibrate strategies as needed.
IV. ROLES AND RESPONSIBILITIES
A. The Disease Prevention and Control Bureau (DPCB) shall:
1. Provide technical assistance and capacity building on the conduct of
school-based MR-Td-HPV vaccination, in collaboration with professional and
civil societies;
Coordinate with the Supply Chain Management Service (SCMS) to ensure the
availability of vaccines down to the Local Government Unit (LGU) level
throughout the implementation of the conduct of school-based MR-Td-HPV
vaccination;
Coordinate with the Health Promotion Bureau with regard to increasing the
awareness on the conduct of school-based MR-Td-HPV vaccination; and
Monitor and evaluate the implementation of school-based MR-Td-HPV
vaccination services and outcome indicators.

B. The Health Promotion Bureau (HPB) shall:

I. Develop social and behavior change (SBC) strategies for vaccine-preventable
diseases and school based immunization (SBI);
2: Cascade SBC plan and Communication Packages to the Centers for Health
Development (CHDs) and Ministry of Health - Bangsamoro Autonomous
Region in Muslim Mindanao (BARMM), partners, and stakeholders for
localization and dissemination;
Collect data on behavioral determinants of target parents and guardians for
school-based immunization;
Support the DepEd in monitoring the accomplishment of indicators and
standards related to vaccination in the implementation of the Oplan Kalusugan
sa DepEd-Healthy Learning Institutions (OKD-HLI) program, and propose
recommendations as appropriate; and
Evaluate effectiveness of SBC strategies in promoting the conduct of
school-based immunization services to guide evidence-based research and
policy making.
C. The Epidemiology Bureau (EB) shall enforce the implementation ofthe existing
DOH Guidelines:
1: Administrative Order No. 2016-2006 entitled “Adverse Events Following
Immunization (AEFI) surveillance and response:™ and
2: Administrative Order No. 2016-0025 entitled, guidelines on the Referral
System for Adverse Events.
D. The Supply Chain Management Service (SCMS) shall be responsible for the
distribution and monitoring of vaccines.

~~
E. The Communication Office (COM) shall conduct media-facing activities to
increase awareness and participation for SBI.

The Centers for Health Development (CHDs) and Ministry of

Health-Bangsamoro Autonomous Region in Muslim Mindanao
(MOH-BARMM) shall perform the following:
1. The National Immunization Program (NIP) shall:
a. Conduct orientation for concerned stakeholders regarding the policy and
promote its
adoption and implementation;
b. Provide technical assistance and capacity building to LGUs and other
partners on the conduct of MR-Td and HPV school-based immunization;
c. Conduct planning with the Provincial and HUCs, DepEd, and DILG
counterparts in the implementation of the SBI;
d. Submit and analyze submitted weekly accomplishment reports by the
Local Government Units through the reporting tool indicated in Section
D.1.b;
e. Evaluate and monitor the implementation of the policy by both public and
private sectors intheir respective regions; and
f. Support the LGUs in the reproduction ofrecording and reporting forms,
notification letter and consent forms, quick health assessment forms,
immunization cards, among others. as needed.

2. The Health Education and Promotion Units (HEPUs) shall:

a. Conduct demand generation planning with the LGUs, DepEd, and DILG
counterparts in the implementation of the SBI;
b. Implement social and behavior change (SBC) strategies for
vaccine-preventable diseases and school based immunization (SBI):
i. Advocate for school administrators and teachers to become
champions of school-based immunization;
il. Assist schools in educating, getting the consent of, and mobilizing
parents to participate in school-based immunization;
and
iii. Develop reproduce communication packages and materials to
drive demand and support participation in school-based
immunization;
iv. Harmonize other stakeholders such as the private sector,
non-government or civil society organizations, development partners
and religious sector to solicit support for immunization program;
c. Ensure intensification of health promotions regarding SBI together with
routine immunization services within their area of influence; and
d. Support LGUs in the reproduction of materials, as needed.
3. The Regional Epidemiology Surveillance Units (RESUs) shall monitor
reports of AEFI and conduct vaccine safety surveillance and conduct
investigations to reported cases of serious AEFI.
 4. The Cold Chain Managers and/or the Supply Chain Units shall ensure
proper cold chain management at all levels and facilitate allocation and
distribution ofvaccines to LGUs and monitor stock inventory for immediate
replenishment, as needed.

The Communication Management Units (CMUs) shall develop crisis

communication plans for AEFI and issue press releases and engage media to
cover the SBI activities.
G. The Department of Education (DepEd) shall:

1. Disseminate the policy to all School Division Offices (SDOs) for coordination
and planning with their respective counterpart LGUs:
2 Disseminate consent forms upon enrollment or at least two (2) weeks prior to
actual implementation;
Conduct health education and promotion activities to parents and students to
advocate for immunization in collaboration with the local health center, ;
Provide the needed Master List of Learners (Grade 1, Grade 7, and Female
Grade 4) for the year of implementation to their respective counterpart LGUs
at least one (1) month prior to the actual SBI rollout; and
Inform DepEd personnel in SDOs that they may participate voluntarily in the
conduct of fixed-site approach school-based immunization. In this regard, the
school nurses may:
a. Screen immunization records ofstudents for a missed dose, series of doses,
or all vaccines due to the learners;
eo to
Administer vaccines eligible students within the school premises:
Provide follow-up care and additional vaccinations if required; and
d. Perform the recording, data collection and validation ofthe number of
immunized target populations during the implementation period.

H. The Local Government Units (LGUs) shall:

1. Conduct school-based MR-Td and HPV vaccination within their area of
influence in accordance to the guidelines set by DOH;
2. Provide localized support or counterpart (i.e. resources, collaterals, others) for
the implementation ofthe policy;
Allot funds for reproduction of SBI IEC materials and all other relevant forms
for the activity;
Develop strategies for conduct of school-based MR-Td-HPV vaccination
specific to their area of jurisdiction;
wn
Perform data validation and generate reports regarding accomplishment during
the implementation period;
Conduct regular consultation and implementation reviews among respective
LGU personnel, immunization stakeholders, and other organizational partners
to improve service delivery efficiency and address implementation issues/gaps;
and
Submit timely reports to the DOH for monitoring and tracking of progress of
implementation.
I. The Local Health Centers shall:
 1. Conduct social and behavior change strategies to support school-based
immunization;
2. Deploy trained healthcare workers to conduct immunization sessions;
3. Ensure the availability and proper storage and handling of vaccines and related
supplies;
4. Screen the immunization records of students for a missed dose, series of doses,
or all vaccines due to the learners;
5.
6.
Administer vaccinesto eligible students within the school premises;
Provide follow-up care and additional vaccinations if required; and
7. Perform the recording, data collection and validation of the number of
immunized target populations during the implementation period.

J. Professional medical and allied medical associations, academic institutions,

non-government organizations, development partners and the private sector shall
be enjoined to support the implementation of the catch-up immunization guidelines
and disseminate it to the areas of their influence.

For dissemination and strict compliance.

By Authority of the Secretary of Health:

Digitally signed by
Maestral Mary Ann
Palermo
Date: 2025.07.17

MARY ANN PALERMO-MAESTRALS ify, ¥BA-HA, FPPS, CHA, FPCHA

Undersecretary of Health
Public Health Services Cluster
Universal Health Care - Health Services Cluster Area II (NCR and Southern
Luzon) and Area III (Visayas)
is
Annex A: Notification Letter and Consent Form Template

Republika ng Pilipinas
Rehiyon,
BAGONG PrLIPINAS

NOTIFICATION LETTER

DATE:

DIVISION:
SCHOOL:

Dear Parent Guardian:

We wish to inform you that our school, in coordination with the Department of Health (DOH) and the Local Government Unit (LGU),
will be conducting the annual Bakuna Eskwela campaign on . During this activity, the following vaccines will be
provided free of charge:
a. Measles-Rubella (MR) and Tetanus-Diphtheria (Td) vaccines for Grade and Grade 7;
1
b. Humanpapilloma Virus (HPV) vaccine for Grade 4 females.

Please accomplish the Acknowledgement and Consent Form below and submit to your child's school advisor on or before
For further questions clarifications on this matter, please get in touch with the Principal School Head.
/

Thank you very much.

Very truly yours,

Name of School Head Principal

ACKNOWLEDGEMENT AND CONSENT

1 have read and understood the information regarding the mtended immunization services to be given to my child.

(Name of the Child [Date of Birth (mm/dd/yyyy)

Sumame: First Name: Middle Name:

Contact Information Age Sex

Contact Number:
|
PRE-VACCINATION CHECKLIST (FOR PARENT/GUARDIAN TO COMPLETE)
four consent re re your child

can be immunized at school. Request clearance from your physician if any of the following
applies (kindly check (v) if any condition appiies to your child):

of
{J My child had a history severe allergy to
measles-containing or Td vaccines
[J My child has a severe illness:
[OJ Primary immune — deficiency disease

(J Suppressed immune response from medications

[OJ Leukemia

JO Lymphoma
Other generalized malignancies
[0 None, my child is relatively healthy.

‘CONSENT FOR IMMUNIZATION

(Please check in the box provided)
(J Yes, I will allowmy child to be provided with immunization services as per DOH recommendation.
[J Grade 1 OR, Td) [J
Grade 4 GV) [1] Grade 7 (VR, Td)
[J No, Iwill not allow my child to receive the immunization service because

I understand that by opting out of the

required immunizations, my child may be at a higher rizk of contracting
vaccine-preventable diseases. By signing this waiver, I acknowledge that I have read and understood the information provided
above.

Name and Signature of Parent Guardian

 Annex B: Recording Form 1 — Masterlist of Grade 1 Students

SCHOOL-BASED IMMUNIZATION
Recording Form 1: Masterlist of Grade 1 Students

Namoof School

Distrct/Municipality:

0 by

Date of MCV s
Vaccine Given
Reosived
COMSEM SIP picory or Deferral Refusal
(Surname, First Name, MI) Allergies
Lote
Mcvi|Mevz| Sie Lot Bate]
v N MR 2 Ta
Pr

Name 4 Signature of Supervisor Name & Signature of Vaccinator 1

Name & Signature of Vaccinator 2 Name & Signature of Recorder

REASONS FOR BEING UNVACCINATED

(Select all that apply for the HK)
Code Reasons
1
Parent was absent/ away from home Code Reasons
2 Fear of vaccine Side effect 10 of trust in the vaccinator
Lack
3 Vatone salety issues [dengue vaccine experience, past adverse experience, etc.) 11 Child just recovered from illness or just dischaged from the
4 Child already has complete routine vaccination, extra vaccine dose not necessary, hospital, the parent/ caregiver refused
50 parents refused 12 Unaware of the campaign
5 Fear of COVID transmission 13 Vaccine team did not visit
6 Vaccine percewvedto be not effective, of low-quality or on near-expiry 14 Child was a from a different area
7 Client is a newborn and parents believed that ner/his child is too young to be 15 Child was acutely sick or not feeling well
16 Do not know/ declined to respond
given vacunation
8 Chile was already vaccinated by private MO, against advised by privata MDs, thus 17 Outright refusal
parents/ caregiver refused 18 Other {specify)
9 Paculiar personal beliefs or misconceptions of the parents or caregiver on
vacon tion; Against religious beliefs
 Annex C: Recording Form 2 — Masterlist of Grade 7 Students

SCHOOL-BASED IMMUNIZATION
Recording Form 2: Masterlist of Grade 7 Students

Name
of Schoo!
MR:
Number of v

Number of \
din vals)
Unused(in vials)

To be d out by Vac

Date of Birth
Date of MCV
Received
Consent Slip History of
SOK ody Vaccine Given
Complete Address Age Deterral Refusal Reasons
(Sumame, First Name, MI) MM/DD/YYYY Allergies Lottac Cotte Sas
MCVi|MCV2( VY
N Y N MR1 nh Na.
MR 2
nhs Te Na.
h

Name & Signature of Supervisor Name & Signature of Vaccinator 1

Name & Signature of Vaccinator 2 Name & Signature of Recorder

REASONS FOR BEING UNVACCINATED

(Select all that apply for the HH)
Code Reasons
1 Parent w, asent/ away from home Code Reasons
2 Fear of vaccine Side effect 10 Lack of trust in the vaccinator
3 Vaccine safety issues (dengue vaccine experience, Juetse experience, ele) 11 Child just recovered rom illness or just disc! ged from the
4 Child already has complete routine vaccination, e ra vaccine dose not necessary, hospital, the parent/ caregiver refused
) parents refused 12 Unaware of
the campaign
5 Fear of COVID transmission 13 Vaccine team did not visit
6 Vaccine perceived to
be not effective, of low-quality or on near-expiry 14 Child was a from a different area
7 Client isa newborn and parents believed that her/his child is too young te be 15 Child was acutely sick or not
feeling viell
given vaccination 16
17
Do not know/ declined
Outright refusal
to
respond
§ Child was already vaccinatad by private MD, against advised by privata MDs, thus
parents/ caregiver refused 18 Other (specify)
9 Peculiar personal beliefs or misconceptions of the parents or caregiver on
vaccination, Against religious beliefs
 Annex D: Recording Form 3 — Masterlist of Grade 4 Female Students

SCHOOL-BASED IMMUNIZATION
Recording Form 3: Masterlist of Grade 4 Female Students

Regon Name of School: ction.

HPV
Barangay ty Number of
Number of Vaccine Used
Date: Number of

ith Canter

EE
Vaccination Team To be filled out by Vaccination Team

(Sumame, First Name, MI)

Date 0 PAY
i
Date of HPV
-
Received
Consent Si .
P| -
wistory of
Allergies
Sick today?
vaccine
ei
SALGiven
Deferral Refusal Reasons
SE
MM/DD/YYYY 2 /Bate
[HPv1|SEE
:

HPV 1|HPV2| Vv N Y N Hey 2

Name & Signature of Supervisor Name & Signature of Vaccinator 1

Name & Signature of Vaccinator 2 Name & Signature of Recorder

REASONS FOR BEING UNVACCINATED

(Select all that apply for the HH)
Code Reasons
1 Parent was absent/ away from home Code Reasons
2 Fear of vaccine Side effect 10 Lack of trust in the vaccinator
3 Vaccine safety issues (dengue vaccine experience, past adverse experience, etc.) 11 Child just recovered from illness or
just dischaged from the
1 Child already has complete routine vaceination, extra vaccine dose not necessary, hospital, the parent/ caregiver refused
“0 parents refused 12 Unaware of the campaign
5 Fear of COVID transmission 13 Vaccine team did not visit
6
7
Vaccine perceived to be not effactive, of low-quality or on near-expiry
Client 1s 3 newborn and parents believed that her/his child 1s too young to be
14
15
Child was
afrom a different area
Child was acutely sick or not feeling well
16 Do not know/ declined to respond
given vaconation
8 Child was already vaccinated by private MD, against advised by private MDs, thus 17 Outright refusal
parents! caregiver refused 18 Other (specify)
9 Peculiar personal beliefs or misconceptions of the parents or caregiver on
vacgination, Against religious beliefs
 Annex E. Quick Links to Readiness Assessment Tool (RAT)

Levels of Implementation Link to RAT

Regional https://web.inform.unicef.org/x/bcrB3DWF

Provincial https://web.inform.unicef.org/x/030lbAda

City/Municipality https://web.inform.unicef.org/x/SjL.20gES

School https://web.inform.unicef.org/x/KSPtSCPs

Feedback https://web.inform.unicef.org/x/cpzTk4xk
 Annex F. Quick Health Assessment for School-based Immunization

QUICK HEALTH ASSESSMENT FOR SCHOOL-BASED INDMUNIZATION

(MR. Td. and HPV Vaccination)

Name of the Child Date of Birth (mm/dd/yyvy)

Surname: First Name: Middle Name

Contact Information Age Sex

Contact Number: Name of Barangay (School): |
-
School:

QUICK HEALTH ASSESSMENT

Mark all appropriatz spaces/boxes with a check (\)
Questions Yes No Decision Remarks

|
If Yes.
DEFER
vaccination;
refer for
Does the child have fever medical
pgp
1.
(237.6°C)7 management;
and seta
Temp:)
—
define date
for the
vaccination
If pregnant or
suspected to
2. Date of last menstruation. be,
if applicable: DONOT
GIVE
MR/HPV
Vaccine
Note:
o Malnutrition, low-grade fever, mild respiratory factions, dicrriza and other minor illns
not be considersd as contraindication:

Immunization Card Mother Baby Book available? J] Yes Ne

Assessed by:

Signature over printed name of the health worker/screener

Date (mm dd vvvv):
 Annex G. School-Based Immunization Card Template

eye
SaBagong

APA
[LEE

Vaccination Card for

School-age Children
Child's Name:

Date of Birth:

(Vaccination given)
Vaccine Type
Date

(Measles-Rubella)

(Tetanus-Diphtheria)

HPV*
(Human Papilloma Virus)

Others:

Keep this card for future reference *For applicable areas only
 ,
FEL
Annex H. Summary Reporting Form
School-Based Immunization
SUMMARY REPORTING Form: RHU Consolidated Accomplishment Form Report

Ra
DAILY

[I
PovincelCity: MunicipallCity:
Date:

Grade 1 Grade 4 Female Grade 7

Students Students Students Students
vaccinated |vaccinated| Total no. of deferred Total no. of refusal
No. of female students Total no. of deferred Total no. of refusal vaccinated |vaccinated| Total no. of deferred Total no. of refusal
vaccinated
wl MR wl Td Total
no. of
oso
students
wIMR wi Td

s envolled|
1st 1st 2nd 1st
dose dose dose dose enrolled
enrolled No. % No. %z |MR| % [Td % (MR| % [Td % % % % No. % No. %Z |MR| % Td %
of of of of
HPV HPV HPV HPV

Grade ©: Grade 7: Grade 4 Female:

MR: [oS wv:
(avis) Received (a
id). vk)
vols
Mhnbes of Vaccine Received Member of Vaccine Number of Vaccine Received fm

Nenber of Vaccine Ured( umber of Vaccine Used vis) Number of Vaccine Used vis)
Nomber of Vaccine Unused
vids) umber of Vaccine Usesedf
vid} Numb of Vaccine
Unni vibk
vf
Te: Te:

vis)
Mme

vss)
Hhambes of Vaccine Received (a vide of Vaccine Received (a

vif
thamber of Vaccine Used Mamber of Vaccine Used
umber of Vaccine Unesed(invinek___ Mumba of Vaccine Unused
Outright retusa
 Annex I: List of Immediately Notifiable AEFIs and First-line Management

Adverse event Case definition First-line Treatment Vaccine

Anaphylactoid Exaggerated acute allergic reaction, Self-limiting; antihistamines All
reaction (acute occurring within 2 hours after may be helpful.
hypersensitivity immunization, characterized by one
reaction) or more of the following:
eo
Wheezing and shortness of
breath due to bronchospasm
e One or more skin
manifestations, e.g. hives,
facial oedema, or
generalized oedema. Less
severe allergic reactions do
not need to be reported.
e Laryngospasm/laryngeal
oedema

Notifiable if the onset is within 24 to

48 hours after immunization
Anaphylaxis Severe immediate (within hour)
1
Epinephrine 1:1,000 formulation All
allergic reaction leading to circulatory
failure with or without bronchospasm ® Less than 2 years
and/or laryngospasm/laryngeal 0.0625 ml (1/16)
oedema. ® 2-5years 0.125 ml (1/8)
6-11 years 0.25 ml (1/4)
Notifiable if the onset is within 24 to eo Over 11 years 0.5 ml
48 hours after immunization (1/2)
Arthralgia Joint pain usually includes the small Self-limiting; analgesics Rubella, MMR
peripheral joints. Persistent if
lasting
longer than 10 days, transient: if
lasting up to 10 days

Notifiable if the onset is within 1

month after immunization

Brachial neuritis Dysfunction of nerves supplying the Symptomatic only; analgesics Tetanus
arm/shoulder without other
involvement of the nervous system. A
deep steady, often severe aching pain
in the shoulder and upper arm
followed in days or weakness by
weakness and wasting in
arm/shoulder muscles. Sensory loss
may be present, but is less prominent.
May present on the same or the
opposite side to the injection and
sometimes affects both arms.

Notifiable if the onset is within 3

months after immunization
Encephalopathy Acute onset of major illness No specific treatment Measles-
characterized by any two ofthe available; supportive containing,
following three conditions: seizures, care. Pertussis-
severe alteration in level of containing
consciousness lasting for one day or
more distinct change in behavior
lasting one day or more. Needs to
 occur within 48 hours of DTP vaccine
or from 7 to 12 days after measles or
MMR vaccine, to be related to

~~
immunization.
Injection site abscess |Fluctuant or draining fluid filled Symptomatic; All
lesion at the site of injection. paracetamol
Bacterial if evidence of infection
(e.g. purulent, inflammatory signs,
fever, culture), sterile abscess if not.

Notifiable ifthe onset is within 7 days

after immunization
Seizures Occurrence of generalized Self-limiting; supportive care; |All, especially
convulsions that are not accompanied |paracetamol and cooling if DTP, MMR
by focal neurological signs or febrile; rarely Measles
symptoms. Febrile seizures: if anticonvulsants
temperature elevated >38°C (rectal)
Afebrile seizures: if temperature
normal

Notifiable if the onset is within 14

days after immunization
Sepsis Acute onset of severe generalized Critical to recognize All
illness due to bacterial infection and
confirmed (if possible) by positive
|and treat it
early. Urgent
transfer to hospital for
blood culture. Needs to be reported as |parenteral antibiotics
a possible indicator of program error. |and fluids.

Notifiable if the onset is within 7 days

after immunization
Severe local reaction [Redness and/or swelling centered at [Settles spontaneously All
the site of injection and one or more [within a few days to a week.
of the following: Symptomatic treatment with
e Swelling beyond the nearest [analgesics. Antibiotics are
joint inappropriate
e Pain, redness, and swelling
of more than 3 days duration
e Requires hospitalization.

Notifiable if the onset is within 7 days

after immunization.
Local reactions of lesser intensity
occur commonly and are trivial and
do not need to be reported.
Thrombocytopenia [Serumplatelet count of less than Usually mild and self- MMR
150,000/ml leading to bruising and/or |limiting; occasionally
bleeding may need steroid or
platelets
Notifiable the onset is within 3
if

months after immunization

Toxic shock Abrupt onset of fever, vomiting and |Critical to recognize and treat All
syndrome (TSS) watery diarrhea within a few hours of early. Urgent transfer to hospital
immunization. Often leading to death for parenteral antibiotics and
within 24 to 48 hours. Needs to be fluids.
reported as a possible indicator of
program error.

Notifiable if the onset is within 24 to

 48 hours after immunization

*Brighton collaboration has developed case definitions for many vaccine reactions and is available at: www.brighton collaboration.org.
References: Manual of Procedures for Surveillance and Response to AEFI, 2014
AO 2023-0007: Revised Omnibus Guidelines on the Surveillance and Management of Adverse Events Following Immunization)
Immunization Safety Surveillance. WHO. Guidelines for managers of immunization programmes on reporting and investigating adverse
events following immunization
 Annex J: Flow and Submission of Reports

~~
Sa
To be
ent nton Type of report Responsible Person
0
Schedule of Report

Recording Form 1:
Masterlist of Grade 1

Students

Recording Form 2: Local Health

School Masterlist of Grade 4 Center/Vaccination RHU Daily
Students Team

Recording Form 3:
Masterlist of Grade 4
Students
Consolidated
RHU accomplishment report by |RHU Midwife PHO/CHO Weekly
Schools per Municipalities

PHO/CHO Analysis report of Provincial/City NIP RHO

municipalities Coordinator Weekly

NIP
RHO Bulletin report of prov/city Regional CO-NIP Weekly
Coordinator
CO Bulletin report of CHDs |DPCB NIP PHSC U Weekly